ProCE Banner Activity

Conversations autour du cancer portant sur l'élargissement du paysage thérapeutique des inhibiteurs de CDK4/6 dans le traitement du cancer du sein HR+/HER2-

PDF

Read these slide notes translated in French to follow along with the associated downloadable slideset providing an overview of CDK4/6 inhibitors in HR+/HER2- breast cancer from early stage through metastatic disease. 

Released: July 26, 2024

Expiration: July 25, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation